LONDON – A rapid, high precision method for diagnosing sepsis by assessing the behavior of neutrophils in a single drop of blood, was reported by researchers at Massachusetts General Hospital this week. Read More
Orthofix International NV won FDA 510(k) clearance for its internal fixation system G-beam Fusion for patients with Charcot foot. The beaming system can align, fixate and stabilize the foot by implanting beams in the lateral and medial foot columns. Charcot foot often is associated with unmanaged diabetes and can lead to nerve damage, deteriorated foot bones and eventual breakdown of the foot. Read More
